Researchers find weakness in hep C virus

Researchers from the University of New South Wales say they've discovered not one but two "Achilles heels" within the hepatitis C virus. The diseases' first weak point is in transmission, when it must move from person to person. The second comes three months after infection; the number of viral variants drops as the immune system responds, providing a window that may make it easier to target the virus. Article

Suggested Articles

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.